Kathleen Marie Sherwood, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1275 Mcconnell Dr, Suite E, Decatur, GA 30033 Phone: 404-321-0082 Fax: 404-321-2007 |
Dr. Bernadette Julia Bigoms, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1862 Candler Rd, Suite A, Decatur, GA 30032 Phone: 404-288-7559 |
Dr. Lisa K Williams, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 3802 N Druid Hills Rd, Decatur, GA 30033 Phone: 404-874-2002 Fax: 404-874-0390 |
Dr. Kendrick D Mcqueen, D.C. Chiropractor - Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4292 Memorial Dr, Suite B, Decatur, GA 30032 Phone: 404-548-5154 Fax: 404-393-3450 |
Total Integrative Health Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 4150 Snapfinger Woods Dr, Decatur, GA 30035 Phone: 404-288-9000 |
Anthony Hayden, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 4982 Covington Hwy, Decatur, GA 30035 Phone: 404-288-8433 |
Dr. Gretchen Lee Gibbs, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2298 Lawrenceville Hwy, Decatur, GA 30033 Phone: 404-325-2856 Fax: 404-315-0633 |
Wyatt Evans Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2293 Candler Rd, Decatur, GA 30032 Phone: 404-284-1255 |
News Archive
White House officials on Thursday highlighted a budget proposal to spend $14 billion over a decade to expand a health care tax credit for small businesses, a move they say would benefit about 4 million workers this year.
A new study has concluded that both systolic and diastolic blood pressure is associated with the risk of heart attack and stroke.
Researchers at the University of York have found that Scottish hospitals have experienced slower reductions in inpatient deaths than their English counterparts.
A simple test can accurately identify which newborn babies are at risk for developing dangerous levels of jaundice, according to researchers at The Children's Hospital of Philadelphia.
YM BioSciences Inc., today reported that the Phase I/II clinical trial for its orally available JAK1/JAK2 inhibitor, CYT387, in patients with myelofibrosis has been expanded to five sites. Of the additional sites, the Stanford Cancer Center (Stanford, California) under Principal Investigator Jason Gotlib, MD has already commenced enrolling patients.
› Verified 1 days ago